B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Mk 212

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Mk 212, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

nn
3 shared targets
bufotenine
2 shared targets
pimavanserin
2 shared targets
rizatriptan
3 shared targets
gepirone
2 shared targets
sb
2 shared targets
rs
2 shared targets
idalopirdine
3 shared targets
mesulergine
3 shared targets
gr
3 shared targets
Loading evidence profile...

This evidence profile for Mk 212 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.